omniture
VIVA BIOTECH HOLDINGS / PORDA HAVAS

Latest News

Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi

SHANGHAI, Sept. 28, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnova...

2022-09-28 18:31 1780

Viva Biotech Announced 2022 Interim Results

Order Backlog Expected to Empower Future Growth with Increasing Long-term Competitive Advantages F...

2022-08-29 23:55 3588

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva Bio...

2022-07-27 21:30 2246
12